322 related articles for article (PubMed ID: 32556722)
1. Glial cell line-derived neurotrophic factors (GFLs) and small molecules targeting RET receptor for the treatment of pain and Parkinson's disease.
Mahato AK; Sidorova YA
Cell Tissue Res; 2020 Oct; 382(1):147-160. PubMed ID: 32556722
[TBL] [Abstract][Full Text] [Related]
2. Small Molecules and Peptides Targeting Glial Cell Line-Derived Neurotrophic Factor Receptors for the Treatment of Neurodegeneration.
Sidorova YA; Saarma M
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32911810
[TBL] [Abstract][Full Text] [Related]
3. [Glial cell line-derived neurotrophic factor family ligands and their therapeutic potential].
Sidorova YA; Saarma M
Mol Biol (Mosk); 2016; 50(4):589-598. PubMed ID: 27668599
[TBL] [Abstract][Full Text] [Related]
4. Novel RET agonist for the treatment of experimental neuropathies.
Viisanen H; Nuotio U; Kambur O; Mahato AK; Jokinen V; Lilius T; Li W; Santos HA; Karelson M; Rauhala P; Kalso E; Sidorova YA
Mol Pain; 2020; 16():1744806920950866. PubMed ID: 32811276
[TBL] [Abstract][Full Text] [Related]
5. Functional mapping of receptor specificity domains of glial cell line-derived neurotrophic factor (GDNF) family ligands and production of GFRalpha1 RET-specific agonists.
Baloh RH; Tansey MG; Johnson EM; Milbrandt J
J Biol Chem; 2000 Feb; 275(5):3412-20. PubMed ID: 10652334
[TBL] [Abstract][Full Text] [Related]
6. A Novel Small Molecule GDNF Receptor RET Agonist, BT13, Promotes Neurite Growth from Sensory Neurons
Sidorova YA; Bespalov MM; Wong AW; Kambur O; Jokinen V; Lilius TO; Suleymanova I; Karelson G; Rauhala PV; Karelson M; Osborne PB; Keast JR; Kalso EA; Saarma M
Front Pharmacol; 2017; 8():365. PubMed ID: 28680400
[TBL] [Abstract][Full Text] [Related]
7. Structural studies of GDNF family ligands with their receptors-Insights into ligand recognition and activation of receptor tyrosine kinase RET.
Wang X
Biochim Biophys Acta; 2013 Oct; 1834(10):2205-12. PubMed ID: 23085183
[TBL] [Abstract][Full Text] [Related]
8. Plasma membrane localization of the GFL receptor components: a nexus for receptor crosstalk.
Donnelly CR; Pierchala BA
Cell Tissue Res; 2020 Oct; 382(1):57-64. PubMed ID: 32767110
[TBL] [Abstract][Full Text] [Related]
9. GDNF family ligand dependent STAT3 activation is mediated by specific alternatively spliced isoforms of GFRα2 and RET.
Zhou L; Too HP
Biochim Biophys Acta; 2013 Dec; 1833(12):2789-2802. PubMed ID: 23872421
[TBL] [Abstract][Full Text] [Related]
10. Targeting the glial-derived neurotrophic factor and related molecules for controlling normal and pathologic pain.
Merighi A
Expert Opin Ther Targets; 2016; 20(2):193-208. PubMed ID: 26863504
[TBL] [Abstract][Full Text] [Related]
11. c-Src is required for glial cell line-derived neurotrophic factor (GDNF) family ligand-mediated neuronal survival via a phosphatidylinositol-3 kinase (PI-3K)-dependent pathway.
Encinas M; Tansey MG; Tsui-Pierchala BA; Comella JX; Milbrandt J; Johnson EM
J Neurosci; 2001 Mar; 21(5):1464-72. PubMed ID: 11222636
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of glial cell line-derived neurotrophic factor and neurturin in RET/GFRalpha1-expressing cells.
Lee RH; Wong WL; Chan CH; Chan SY
J Neurosci Res; 2006 Jan; 83(1):80-90. PubMed ID: 16294336
[TBL] [Abstract][Full Text] [Related]
13. Expression and function of GDNF family ligands and receptors in the carotid body.
Leitner ML; Wang LH; Osborne PA; Golden JP; Milbrandt J; Johnson EM
Exp Neurol; 2005 Feb; 191 Suppl 1():S68-79. PubMed ID: 15629763
[TBL] [Abstract][Full Text] [Related]
14. Evidence for a ligand-specific signaling through GFRalpha-1, but not GFRalpha-2, in the absence of Ret.
Pezeshki G; Franke B; Engele J
J Neurosci Res; 2001 Nov; 66(3):390-5. PubMed ID: 11746356
[TBL] [Abstract][Full Text] [Related]
15. Glial Cell Line-Derived Neurotrophic Factor Family Ligands, Players at the Interface of Neuroinflammation and Neuroprotection: Focus Onto the Glia.
Kotliarova A; Sidorova YA
Front Cell Neurosci; 2021; 15():679034. PubMed ID: 34220453
[TBL] [Abstract][Full Text] [Related]
16. Glial cell line-derived neurotrophic factor receptor Rearranged during transfection agonist supports dopamine neurons in Vitro and enhances dopamine release In Vivo.
Mahato AK; Kopra J; Renko JM; Visnapuu T; Korhonen I; Pulkkinen N; Bespalov MM; Domanskyi A; Ronken E; Piepponen TP; Voutilainen MH; Tuominen RK; Karelson M; Sidorova YA; Saarma M
Mov Disord; 2020 Feb; 35(2):245-255. PubMed ID: 31840869
[TBL] [Abstract][Full Text] [Related]
17. Neurturin-mediated ret activation is required for retinal function.
Brantley MA; Jain S; Barr EE; Johnson EM; Milbrandt J
J Neurosci; 2008 Apr; 28(16):4123-35. PubMed ID: 18417692
[TBL] [Abstract][Full Text] [Related]
18. Ret-dependent and Ret-independent mechanisms of Gfl-induced sensitization.
Schmutzler BS; Roy S; Pittman SK; Meadows RM; Hingtgen CM
Mol Pain; 2011 Mar; 7():22. PubMed ID: 21450093
[TBL] [Abstract][Full Text] [Related]
19. GDNF family receptor complexes are emerging drug targets.
Bespalov MM; Saarma M
Trends Pharmacol Sci; 2007 Feb; 28(2):68-74. PubMed ID: 17218019
[TBL] [Abstract][Full Text] [Related]
20. The role of glial cell line-derived neurotrophic factor family member artemin in neurological disorders and cancers.
Zhu S; Li Y; Bennett S; Chen J; Weng IZ; Huang L; Xu H; Xu J
Cell Prolif; 2020 Jul; 53(7):e12860. PubMed ID: 32573073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
